Search Results - Maxim Grymonprez

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis

    Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis by Maxim Grymonprez, Stéphane Steurbaut, Tine L. De Backer, Mirko Petrović, Lies Lahousse

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis

    Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis by Maxim Grymonprez, Cynthia Simoens, Stéphane Steurbaut, Tine L. De Backer, Lies Lahousse

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study

    Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study by Maxim Grymonprez, Tine L. De Backer, Xander Bertels, Stéphane Steurbaut, Lies Lahousse

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study

    Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study by Maxim Grymonprez, Mirko Petrović, Tine L. De Backer, Stéphane Steurbaut, Lies Lahousse

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

    The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation by Maxim Grymonprez, Mirko Petrović, Tine L. De Backer, Stéphane Steurbaut, Lies Lahousse

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study

    Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide coh... by Maxim Grymonprez, Laura Carnoy, Andreas Capiau, Koen Boussery, Els Mehuys, Tine L. De Backer, Stéphane Steurbaut, Lies Lahousse

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Chronic obstructive pulmonary disease and the development of atrial fibrillation

    Chronic obstructive pulmonary disease and the development of atrial fibrillation by Maxim Grymonprez, Vincent Vakaet, Maryam Kavousi, Bruno H. Stricker, M. Arfan Ikram, Jan Heeringa, Oscar H. Franco, Guy Brusselle, Lies Lahousse

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: